As of Wednesday close, Tenax Therapeutics Inc.’s (NASDAQ:TENX) stock was up $0.02, moving up 8.01 percent to $0.32. The average number of shares traded per day over the past five days has been 447,400 shares. 4 times new highs have been achieved over the past 5 days, with a $0.0148 gain in that time frame. In the last twenty days, the average volume was 299,190, while in the previous 50 days, it was 465,306.
Since last month, TENX stock rose 3.02%. Shares of the company fell to $0.2841 on 08/08/23, the lowest level in the past month. A 52-week high of $7.40 was reached on 02/02/23 after having rallying from a 52-week low of $0.25. Since the beginning of this year, TENX’s stock price has dropped by -85.47% or -$1.9042, and marked a new high 7 times. However, the stock has declined by -95.62% since its 52-week high.
Financial Health
In the three months ended March 30, Tenax Therapeutics Inc.’s quick ratio stood at 15.40, while its current ratio was 15.40, showing that the company is able to pay off its debt. Based on annual data, TENX earned $4000.0 in gross profit and brought in $11.06 million in revenue.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. While analysts expected Tenax Therapeutics Inc. to report -$0.37 quarterly earnings, the actual figure was -$0.15 per share, beating the consensus estimate by 59.50%. During the quarter, the company generated -$1.24 million in EBITDA. The liabilities of Tenax Therapeutics Inc. were 0.82 million at the end of its most recent quarter ended March 30. The value of shareholders’ equity is $23.86 million.
Technical Picture
This quick technical analysis looks at Tenax Therapeutics Inc.’s (TENX) price momentum. With a historical volatility rate of 56.50%, the RSI 9-day stood at 62.83% on 16 August.
With respect to its five-day moving average, the current Tenax Therapeutics Inc. price is up by +4.79% percent or $0.0148. At present, TENX shares trade -6.69% below its 20-day simple moving average and -38.44% percent below its 100-day simple moving average. However, the stock is currently trading approximately -7.49% below its SMA50 and -87.92% below its SMA200.
Stochastic coefficient K was 41.26% and Stochastic coefficient D was 31.51%, while ATR was 0.0253. Given the Stochastic reading of 71.02% for the 14-day period, the RSI (14) reading has been calculated as 56.73%.
Analyst Ratings
Ladenburg Thalmann upgraded its rating on Tenax Therapeutics Inc. (NASDAQ: TENX) to a Buy in a note to investors on May 18, 2017. The analysts firm previously had a Neutral rating on the stock.Tenax Therapeutics Inc. (TENX) has been rated Buy by analysts. According to 0 brokerage firms, TENX is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Tenax Therapeutics Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $5.50, the current consensus forecast for the stock is $5.00 – $6.00. Based on these forecasts, analysts predict Tenax Therapeutics Inc. (TENX) will achieve an average price target of $5.50.
